2,493 results
·
45ms
·
Sources: EU EUDAMED, US FDA
Sledgehammer
FDA UDI
Keystone Industries·H66810019651·HC 1 lb Pwd & 8 oz Liq Kit, Lt Fibered Plus
Sledgehammer
FDA UDI
Keystone Industries·H66810019751·SC 25 lb Pwd & 4 Qt Liq Kit, Lt Fibered Plus
Bosworth Softone
FDA UDI
Harry J Bosworth Company·H6680921775P1·Temp Reline 3 oz Pwd & 4 oz Liq Standard Kit, Pink
Glasses: L, LA, LAB, LAC, LAD, LAE, LAF, LBF, LBG, LAG, LBC, LBE, LAY, LAZ, LAH, LAQ, LAW, LB, LBD, LC, LD, LE, LF, LG
FDA registration
LINHAI CHENGYUAN GLASSES CO., LTD·1 product·🇨🇳 China
LZI Fentanyl II Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LZI Oxycodone III Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LZI Fentanyl III Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LZI Methadone II Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
LZI Cotinine II Enzyme Immunoassay
FDA 510(k)
FDA Class 1
·Clinical Toxicology
Versacryl
FDA UDI
Keystone Industries·H66810140391·SC Reline Intro Kit, 1-50g pink Pwd, 1-60 ml pr...
MASTER-DENT
FDA UDI
DENTONICS INC·00816526021210·N-Methasone, Perm Root Canal Filling Material, ...
NA
FDA UDI
Shenzhen AOJ Medical Technology Co., Ltd·06972040110817·
Versacryl
FDA UDI
Keystone Industries·H66810140341·HC Reline Kit, 2-50 g Pink Pwd. 2-60 ml pre-mix...
Bosworth SuperEBA
FDA UDI
Harry J Bosworth Company·H66809210071·15 g Pwd & 6.5 ml Liq Cement Combo Kit, Fast &...
Versacryl
FDA UDI
Keystone Industries·H66810140331·SC Reline Kit, 2-50 g Pink Pwd. 2-60 ml pre-mix...
MULETA BASE 5 PATAS IZQ NEGRO ALUMINIO
Device
EU MDR
·
Eu Md Class 1
·Ortoiberica S.L.·On the market·32 countries
FUNDA DE ESPUMA PREFORMADA IZQ. 44 CM
Device
EU MDR
·
Eu Md Class 1
·Ortoiberica S.L.·On the market·32 countries
FUNDA DE ESPUMA PREFORMADA IZQ. 40 CM
Device
EU MDR
·
Eu Md Class 1
·Ortoiberica S.L.·On the market·32 countries
FUNDA DE ESPUMA PREFORMADA IZQ. 36 CM
Device
EU MDR
·
Eu Md Class 1
·Ortoiberica S.L.·On the market·32 countries
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·ARCHITECT FREE PSA ASSAY